期刊文献+

血液透析串联血液灌流治疗顽固性尿毒症性皮肤瘙痒 被引量:7

Hemoperfusion Connected with Hemodialysis in Treatment of Refractory Uremic Pruritus
下载PDF
导出
摘要 目的:探讨血液透析串联血液灌流治疗顽固性尿毒症性皮肤瘙痒的应用价值。方法:选择尿毒症顽固性瘙痒患者63例,根据治疗方法的不同分为观察组和对照组,观察组患者采用血液灌流串联血液透析治疗,对照组患者选择常规血液透析治疗。结果:1.治疗后,对照组患者平均瘙痒评分分值为(20.43±3.47),较治疗前无明显变化(P>0.05),观察组患者平均瘙痒评分分值为(12.4±3.12),较治疗前显著降低,且显著低于对照组(P<0.05)。2.治疗后,两组患者MMS、BUN及Scr水平均显著低于治疗前,ALB水平均显著高于治疗前(P<0.05)。治疗后,观察组患者MMS水平显著低于对照组(P<0.05)。3.观察组中,随患者血P3-、β2-MG及PTH水平与患者瘙痒评分间均存在直线关系(P<0.05)。结论:血液透析串联血液灌流能够显著改善顽固性尿毒症性皮肤瘙痒的程度。 Objective:To investigate the value of Hemoperfusion connected with Hemodialysis in treatment of refractory uremic pruritus.Methods:63 cases of patients with refractory uremic pruritus were divided into two groups,the observation group were treated with Hemoperfusion connected with Hemodialysis,the control group patients choose conventional hemodialysis treatment.Results:1.After treatment,the itching rating score of the control group were(20.43±3.47),there were no significant change compared with before(P0.05).the itching rating score of the observation group were(12.4±3.12),significantly lower than before treatment and the control group(P0.05).2.After treatment,the average water of two groups of patients with MMS,BUN,and Scr significantly lower than before treatment,ALB,were significantly higher than before treatment(P0.05).After treatment,observed patients MMS levels were significantly lower than the control group(P0.05).3.there were linear relationship between the P3-、β2-MG and PTH levels and the pruritus score(P0.05).Conclusion:hemodialysis connects with hemoperfusion can significantly improve the degree of refractory uremic pruritus.
作者 黄涛 周忠荣
出处 《中国医药导刊》 2012年第10期1716-1717,共2页 Chinese Journal of Medicinal Guide
关键词 尿毒症 皮肤瘙痒 血液透析 血液灌流 Uremia Itchy skin Hemodialysis Blood perfusion
  • 相关文献

参考文献10

二级参考文献52

共引文献83

同被引文献57

  • 1凡心孔,单祖逖,王子娟,刘小莉,施大学,王雪平.血液透析联合血液灌流治疗尿毒症顽固性高血压疗效观察[J].医学信息(医学与计算机应用),2014,0(16):201-202. 被引量:1
  • 2彭隽,兰天飙,车华,余爱荣.ARB和ACEI维持性血液透析患者EPO疗效比较[J].药物流行病学杂志,2006,15(1):8-10. 被引量:4
  • 3Narita I, Iguchi S,Omori K,et al.Uremic pruitus in chronic hemodialysispatients[J].J Nephrol, 2008,21 (2) : 161-165.
  • 4陈香美.血液净化标准操作规程[M].北京:人民军医出版社,2012:50-70.
  • 5Kaur S,Singh NP,Jain AK,et al. Serum C-reactive pro- tein and leptin for assessment of nutritional status in patients on maintenance hemodialysis[J]. Indian J Nephrol, 2012,22(6) :419-423.
  • 6Zaza G, Bernich P, Lupo A. Renal biopsy in chronic kidney disease: lessons from a large Italian registry[J]. Am J Nephrol, 2013,37(3) :255-259.
  • 7Bolasco P, Atzeni A. Erythropoiesis-stimulating agents: switch from intravenous to subcutaneous administration in hemodialyzed patients[J]. Int J Clin Pharmacol Ther, 2011,49(12) :744-749.
  • 8Florit EA, H adad F, Rodriguez-Cubillo B, et al. Anemia in kidney transplants without erythropoietic agents:levels of erythropoietin and iron parameters[J]. Transplant Proe, 2012,44(9) :2590-2592.
  • 9Cianciaruso B, Ravani P,Barrett BJ, et al. Italian random- ized trial of hemoglobin maintenance to prevent or delay left ventricular hypertrophy in chronic kidney disease[J]. J Nephrol,2008,21(6) :861-870.
  • 10Di Raimondo D, Tuttolomondo A, Butta C, et al. Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation[J]. Curr Pharm Des, 2012,18 (28): 4885- 4413.

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部